Bladder Epicheck® for surveillance in high-risk non-muscle-invasive bladder cancer: Initial experience and follow-up proposal-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bladder Epicheck® for surveillance in high-risk non-muscle-invasive bladder cancer: Initial experience and follow-up proposal

Published:2023-10 Issue:8 Volume:47 Page:471-473
ISSN:2173-5786
Container-title:Actas Urológicas Españolas (English Edition)
language:en
Short-container-title:Actas Urológicas Españolas (English Edition)

Author:

Caño Velasco J.,Polanco Pujol L.,Moreno Cortés J.C.,Lafuente Puentedura A.,Hernández Fernández C.

Publisher

Elsevier BV

Subject

General Engineering

Reference15 articles.

1. Cancer Today – IARC. Estimated number of new cases in 2020, worldwide, both sexes, all ages. 2021 [Accessed April 2023]. Available from: https://gco.iarc.fr/today/online-analysis-table.

2. European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ);Gontero,2023

3. Quality of life in patients undergoing surveillance for non-muscle invasive bladder cancer—a systematic review;Nayak;Transl Androl Urol,2021

4. Economic burden of bladder cancer across the European Union;Leal;Eur Urol,2016

5. The burden of bladder cancer care: direct and indirect costs;Mossanen;Curr Opin Urol,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP